Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.
Prostate stromal cells may play binary roles in the process of prostate cancer development. As the first to be encountered by infiltrating prostate cancer cells, prostate stromal cells form the first defense line against prostate cancer progression and metastasis. However, interaction between prostate cancer and stromal cells may facilitate the formation of a tumor microenvironment favoring cancer cell growth and survival. To establish an experimental system for studying the interaction between cancer and stromal cells, we isolated three matched pairs of normal and cancer-associated human prostate stromal clones. In this report, we describe the morphologic and behavioral characteristics of these cells and their effect on LNCaP prostate cancer cells in co-culture. Unlike LNCaP prostate cancer cells, the isolated prostate stromal clones are large fibroblast-like cells with a slow proliferation rate. Growth and survival of these clones are not affected by androgens. The stromal cells display high resistance to serum starvation, while cancer-associated stromal clones have differentiated survival ability. In co-culture experiments, the stromal cells protected some LNCaP prostate cancer cells from death by serum starvation, and cancer-associated stromal clones showed more protection. This work thus established a panel of valuable human prostate stromal cell lines, which could be used in co-culture to study the interaction between prostate cancer and prostate stromal cells.
Sun
Xiaojuan
X
Molecular Urology and Therapeutics, Department of Urology and Winship Cancer Institute, Emory University School of Medicine, 1365B Clifton Road, NE, Suite B5103, Atlanta, GA 30322, USA.
He
Hui
H
Xie
Zhihui
Z
Qian
Weiping
W
Zhau
Haiyen E
HE
Chung
Leland W K
LW
Marshall
Fray F
FF
Wang
Ruoxiang
R
D016923:Cell Death; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002470:Cell Survival; D018920:Coculture Techniques; D006801:Humans; D008297:Male; D011467:Prostate / Q000166:cytology*; D011471:Prostatic Neoplasms / Q000473:pathology*; D017154:Stromal Cells / Q000166:cytology*
In Vitro Cell Dev Biol Anim. 2001 Mar;37(3):127-40
11370803
J Cell Biochem. 2005 Oct 15;96(3):439-46
15988761
Cancer Res. 1991 Jul 15;51(14):3753-61
1712249
Spec Top Endocrinol Metab. 1985;7:101-29
3914094
World J Urol. 1995;13(5):264-76
8580997
Carcinogenesis. 2009 Apr;30(4):698-705
19233959
Prostate. 1990;16(3):263-76
2184419
Biochem Biophys Res Commun. 1996 Mar 27;220(3):858-63
8607856
Eur Urol. 2008 Jun;53(6):1129-37
18262723
Prostate. 2000 Jul 1;44(2):91-103 Jul 1;44(2)
10881018
Prostate. 1999 Dec 1;41(4):233-42
10544296
Urol Clin North Am. 1990 Aug;17(3):661-70
1695786
Cancer. 1994 Aug 1;74(3 Suppl):1030-44
8039137
Int J Cancer. 1994 May 1;57(3):406-12
8169003
Lung Cancer. 2004 Aug;45 Suppl 2:S163-75
15552797
Differentiation. 2002 Dec;70(9-10):473-85
12492490
Prostate. 2006 Nov 1;66(15):1664-73
16902972
Urol Oncol. 2000 Nov 1;5(6):258-264
11008094
J Urol. 1987 Jan;137(1):140-5
3795357
Cancer Surv. 1995;23:33-42
7621472
Prostate. 2010 Apr 1;70(5):518-28
19918799
Semin Cancer Biol. 2005 Apr;15(2):132-7
15652458
J Biol Chem. 1999 Apr 30;274(18):12827-34
10212269
Prostate. 1983;4(5):503-11
6889194
Clin Cancer Res. 2003 Oct 15;9(13):4792-801
14581350
Scand J Clin Lab Invest Suppl. 1996;226:57-63
8981668
Prostate. 1985;7(1):41-51
4080651
J Cell Physiol. 1999 Sep;180(3):431-8
10430183
Mol Endocrinol. 1992 Dec;6(12):2123-8
1491693
Cancer J. 2000 Jul-Aug;6(4):220-33
11038142
Arch Histol Cytol. 2004 Dec;67(5):417-34
15781983
Differentiation. 2002 Dec;70(9-10):506-21
12492493
Cancer Res. 1999 Oct 1;59(19):5030-6
10519419